Jan. 7
2021
RCA January 2021 Newsletter
Research Centers of America Expedite Broad Study on Moderna’s COVID-19 Vaccine
Powerful data on safety and efficacy published in New England Journal of Medicine
Research Centers of America (“RCA”), a CenExel Center of Excellence, joined nearly 100 other clinical research facilities across the United States to test the safety and efficacy of Moderna’s mRNA-1273 vaccine against COVID-19. The published results in The New England Journal of Medicine showcased that the trial enrolled 30,420 volunteers and found an overall vaccine efficacy rate of 94.1%. Although moderate, short-lived reactogenicity occurred more often in the mRNA-1273 group, these reactions are typical for vaccinations. [...]